Rigel宣佈Rezlidhia®（Olutasidenib）在Midh1 Aml的1B/

快訊 · 09/05 19:30

Rigel Announces First Patient Enrolled in Phase 1B/2 Triplet Therapy Trial of Rezlidhia® (Olutasidenib) in Midh1 Aml

Rigel宣佈Rezlidhia®（Olutasidenib）在Midh1 Aml的1B/2三聯療法試驗中招募了第一位患者。